Original BioMedicals Co., Ltd. (6483.TWO) Stock
—
Valuation
Financials & Margins
Valuation & Return Ratios
About Original BioMedicals Co., Ltd.
—
Original BioMedicals Co., Ltd. is led by CEO Cliff C. Wang, employs 25 people, headquartered in Taipei, TW, publicly traded since 2024.
Original BioMedicals Co., Ltd. (6483.TWO) stock trades at $12.00 with a market capitalization of $781.65M. The stock is valued at a negative price-to-earnings (P/E) ratio of -7.50, reflecting a net loss over the last twelve months, price-to-book of 7.04. Over the past 52 weeks the stock has ranged between $9.12 and $20.00, and currently trades 40.0% below its 52-week high.
On profitability, Original BioMedicals Co., Ltd. generates a return on equity (ROE) of -63.64% (negative, reflecting a net loss).
Official website: i-obm.com
Original BioMedicals Co., Ltd. (6483.TWO) — frequently asked questions
What is Original BioMedicals Co., Ltd. (6483.TWO) stock price today?
Original BioMedicals Co., Ltd. (6483.TWO) is currently trading at $12.00, up 4.8% today.
What is 6483.TWO P/E ratio?
Original BioMedicals Co., Ltd.'s P/E ratio is -7.50. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 6483.TWO return on equity (ROE)?
Original BioMedicals Co., Ltd.'s return on equity (ROE) is -63.64%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Original BioMedicals Co., Ltd.'s market cap?
Original BioMedicals Co., Ltd. has a market capitalization of $781.65M.
Does 6483.TWO pay a dividend?
Original BioMedicals Co., Ltd. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 6483.TWO carry?
Original BioMedicals Co., Ltd. has a debt-to-equity ratio of 0.08. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 6483.TWO's profit margin?
Original BioMedicals Co., Ltd. reports a net profit margin of 0.00% — the share of revenue left after every cost, including tax and interest.
What sector is 6483.TWO in?
Original BioMedicals Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 6483.TWO listed on?
Original BioMedicals Co., Ltd. trades on TWO under the ticker 6483.TWO.
What is 6483.TWO's 52-week range?
Over the last year Original BioMedicals Co., Ltd. has traded between $9.12 and $20.00.
Related — Stocks
Popular Stocks
Screens 6483.TWO currently matches
On the figures above, Original BioMedicals Co., Ltd. passes the filters for 5 of our ready-made screens, among them Small Cap Stocks, Stocks Under $100, Stocks Under $50. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.